Shkreli: I'll Win Upcoming Fraud Trial by 'Landslide'

Former Turing Pharmaceuticals CEO Martin Shkreli discusses the controversy surrounding his raising of pricing for the drug Daraprim and talks about his upcoming securities fraud trial on charges related to hedge funds he ran prior to Turing. He speaks on "Bloomberg Daybreak: Americas." (Source: Bloomberg)

Pharma's Bad Boy Martin Shkreli Arrested Today
45:55 - KaloBios Pharmaceuticals Inc. plummeted 50 percent in early trading after the drug company’s CEO Martin Shkreli was arrested in New York on securities fraud charges related to one of his prior companies. Bloomberg's Keri Geiger reports on "Bloomberg Markets." (Source: Bloomberg)
  • Martin Shkreli Charged With Securities Fraud: Capers
  • Turing CEO Martin Shkreli Faces Securities Fraud Charges
  • Turing CEO Martin Shkreli Arrested on Fraud Charges